Drugplain

Vocabria 30 mg/1

cabotegravir sodium · TABLET, FILM COATED · ViiV Healthcare Company

No Recall History
Plain English

Vocabria is a tablet, film coated containing cabotegravir sodium at 30 mg/1, taken oral. Manufactured by ViiV Healthcare Company.

Key Facts

Brand Name
Vocabria
Generic Name
cabotegravir sodium
NDC Code (Product)
49702-248
Manufacturer
ViiV Healthcare Company
Strength
30 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA212887
Marketing Start
01/21/2021

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

viral load increased109 reports
injection site pain105 reports
product dose omission issue89 reports
virologic failure64 reports
hepatitis b63 reports
off label use61 reports
pathogen resistance61 reports
nausea58 reports
headache56 reports
inappropriate schedule of product administration56 reports

Frequently Asked Questions

What is Vocabria used for?

Vocabria contains cabotegravir sodium. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is Vocabria a controlled substance?

Vocabria is not classified as a controlled substance by the DEA.

What is the generic name for Vocabria?

The generic name for Vocabria is cabotegravir sodium. There are no other listed brand versions of cabotegravir sodium.

What is the NDC code for Vocabria 30 mg/1?

The NDC (National Drug Code) for Vocabria 30 mg/1 is 49702-248, listed by ViiV Healthcare Company.

Product NDC

49702-248

Package NDC

49702-248-13

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)